Prokinetics in SIBO & Motility Disorders
|
|
- Melvyn Byrd
- 5 years ago
- Views:
Transcription
1 Prokinetics in SIBO & Motility Disorders Allison Siebecker ND, MSOM, LAc Source: boundless.com Motility Bootcamp, July 2016 AANP, Salt Lake City Ut Prokinetics: Definition Increase transit/motility in GI tract Improve coordination of GI movement Increase LES tone, relax pylorus v Amplify & coordinate GI muscular contractions Can have different sites of action: upper or lower GI Vs Laxative = stimulate BM s, loosen stool Pk can be laxative but often aren t, esp at low dose Pk can be used w/diarrhea to (+) upper GI motility, esp at lower dose Key Points Not all prokinetics are unsafe Side Effects/Reactions are common 1
2 Adapted from Scarpignato 98 and 12, with Ottillinger 13 Prucalopride no no yes yes few Iberogast yes yes yes few Prucalopride helps: nausea, bloating, pain, constipation (Emmanuel 12, Diederen 15) Iberogast helps: nausea, GERD, bloating, cramping/pain, constipation, diarrhea (Ottillinger 13) Prokinetics: Mechanisms of Action Muscarinic Acetylcholine Receptor Agonist: M (+) Acetylcholinesterase Inhibitor: ACh (-) Dopamine 2 Receptor Antagonist: D2(-) Seratonin 3 Receptor Antagonist: 5-HT3 (-) Seratonin 4 Receptor Agonist: 5-HT4 (+) = (+) ACh Motilin Receptor Agonist Cholecystokinin A Receptor Antagonist: CCK-A (-) Opioid Receptor Antagonist Adapted from Scarpignato 98 with Manabe 10, Simmen 06 M3 Opioid receptor receptor agonism antagonism Prucalopride no no yes no no no no Iberogast no yes yes no no yes yes Low Dose Naltrexone no no no no no no yes 2
3 Prokinetic Usage 1. Symptom Relief in Motility or Functional GI Disorders Dosed: tid before meals. Or after/in between meals and first a.m. for GERD, dyspepsia/gastroparesis (sx after meals), bloating v to move food, acid, gas out of St/SI Dosed: qd may enough for constipation depending on Pk Dose: standard Pk dose 2. Prevention of SIBO Relapse (maintenance of remission) Dosed: before bed v to (+) MMC overnight Dose: low dose to prevent return of sx Prokinetics Usage 1. Symptom Relief TID (or QD constipation) Regular dose 2. SIBO Relapse Prevention HS Low Dose Prokinetic Dose Motility, FGI Disorders Sx Relief Pharmaceutical Low Dose Erythromycin (LDE) mg tid-qid Prucalopride 1-4mg qd or 1mg bid-tid Low Dose Naltrexone (LDN) mg hs or bid 2.5mg- diarrhea, 4.5mg- constipation Herbal Iberogast 20 drops tid or PRN Ginger 500mg tid, 1000mg bid MP 2-3caps bid-tid (5Htp, Acetyl L Carnitine, Ginger, Vit C, B6) 3
4 Prokinetic Dose SIBO Relapse Prevention Pharmaceutical Low Dose Erythromycin (LDE) mg at bedtime (hs) Low Dose Prucalopride (LDP) 0.5 mg hs (up to 2 mg if needed) Low Dose Naltrexone (LDN) mg hs or bid 2.5mg- diarrhea, 4.5mg- constipation Herbal Iberogast drops hs Ginger 1000mg hs MP 2-3caps hs or hs & a.m. (5Htp, Acetyl L Carnitine, Ginger, Vit C, B6) Erythromycin & Prucalopride LDE No/weak Abx activity at low dose. Standard Tx for Gastroparesis Delayed SIBO relapse by 2.5 mo (Pimentel 09) SE vary. Tolerance possible. Prolong QT waves. P450 3A4 interactions Prucalopride Safer/stronger alternative to Tegaserod which delayed SIBO relapse by 6mo (Pimentel 09) Dr P thinks may help heal MMC over time. 1 st choice of many GE/most effective Pk SE: h/a, urinary urge, temporary diarr, varied. Tolerance possible. Obtained through Canadadrugs.com. Available in US soon. LDN & Iberogast LDN 68% success for SIBO Prevention, 38% failure (Ploesser 10) v Doesn t work as Pk (not strong enough) in many (Combine w/other Pk) SE: varied, sleep disturbance- titrate up to help avoid Also used for inflammation, depression, Auto Immune dz (=PI-IBS) Iberogast 75-85% success= IBS, Significant Sx improvement= Dyspepsia (Ottillinger) v Miracle for nausea More effective vs metoclopramide, similar vs cisapride = Dyspepsia SE: 0.04%. Safe for long term use, pregnancy, children 4
5 Ginger Ginger & MP MoA: + gastric emptying/mmc, M Rec (+), 5-HT3 (-) (Micklefield 99, Hu 11, Haniadka 13, Wu 08 Thompson 14) SE: 28% GERD/Ginger Burn (Thompson 14) helped by drinking water MP (no studies) Ginger, 5HTP, acetyl L-carnitine, Vit C, B6 MoA: saa + extra ACh/Cholinergic SE: GERD, diarrhea (+ LI motility too) Japanese Daikenchuto Motilin agonist + lots more (Tominaga 13, Nagano 99, Mochiki 10) Thought to effect distal SI & LI best (Nakaji 11) 190mg/kg/day (Endo 14) or 5g tid before meals Processed Ginger 3-5g + Ginseng 3g + Sichuan Pepper (Zanthoxylum piperitum) 2g Bitter Orange (immature/fructus auranti /Zhi Shi)(poncirus fructus) 5-HT4 (+) (Qiu 11, Jiang 14, Kim 13, Shim 10) ingredient in Chaihu Shugan San Triphala Other Natural Prokinetics mild prokinetic, laxative (Mukherjee 97, Jirankalgikar 12, Tamhane 97) How To Choose Pk v When you need to be sure: choose Pruc or LDE Pruc: need effectiveness, chronic cases, constipation, PI-IBS LDE: chronic/recurrent cases w/o constipation, gastroparesis LDN: inflammation, auto-immunity, depression Iberogast: want natural, broad sx relief, nausea Ginger: nausea/gastroparesis, not w/gerd MP: constipation, depression, not w/gerd v PARQ patient & ask their input 5
6 Pk PARQ: Pro s & Con s Prucalopride: Pro: strongest, safe (no QT/p450), low se, may heal MMC over time. Con: tolerance/se possible, expensive, 3wks to get in mail/not FDA approved Eryth: Pro: studied for SIBO, inexpensive/easily available, low se. Con: tolerance/se possible, long-term low-dose Abx, p450 interactions. Cx: preexist Ht cond (can prolong QT), w/berb (p450) LDN: Pro: anti-inflam, used for AI dz & depression, natural MoA. Con: not strong enough for some (1/3+)(tech not Pk), se: sleep disturbance Iberogast: Pro: natural, well studied as a Pk, broad GI sx relief, safe: kids, preg, lactation, no s.e. s in studies. Con: not strong enough for many, indiv se poss Ginger: Pro: natural, anti-nausea/inflam. Con: se: GERD/ginger burn, tolerance, not strong enough for many MP: Pro: (+)BM s/li motility, anti-depressant/sleep aid Con: (+)BM s/li motility, se: GERD/ginger burn, emotional, sleep, not strong enough for many Start/Duration/Stop Start: Sx Relief- any time Dr Scarp suggests LI purging 1 st to avoid anti-peristalsis (not w/diarrhea pt) Start: SIBO prevention- 1-5 days after tx Important to be on Pk between tx courses to hold gains/prevent relapse Plan ahead: Give the Rx/Pk Plan when Tx is given Duration: Sx- ongoing PRN. SIBO- min 3mo, ongoing for many May be stopped at any time- only risk is relapse of Sx or SIBO Stop: Titrate down slowly, esp w/sibo to catch a relapse Other Motility Considerations Stress Decrease stress/sympathetic: Rushing, worrying Increase parasympathetic: Conscious breaths, Gratitude, Rest Meal Spacing/ Overnight Fast 4-5 hrs between meals, 12 hr overnight fast to optimize MMC Physical Tx/Body work Wurn technique, visceral manipulation, cranial osteopathy 6
7 Pk: Pregnancy, Lactation & Pediatrics Preg & Lact: There are no category listing for the low Rx Pk doses used LDE (Cat B at regular Abx dose) Prucalopride is analogous to US Cat B (at regular 2-4mg dose) Safe: LDN, Iberogast, Ginger (max 2g/d) Peds Doses: LDE 25mg, LDN & Prucalopride 0.01mg/kg, Iberogast gtts, Ginger 250mg 7
The Opportunity: c-ibs and pain relief with confidence YKP10811
The Opportunity: c-ibs and pain relief with confidence YKP10811 1 TABLE OF CONTENTS Profile Summary Clinical Data Mode of Action Pharmacologic Profile Safety and Toxicity Profile ADME Overview vs. Competitors
More informationGastrointestinal motility modulating drugs include all compounds which have pharmacological
Pharmacotherapeutics Gastrointestinal Motility Modulating Drugs Oh Young Lee, MD Department of Internal Medicine, Hanyang University College of Medicine E - mail : leeoy@hanyang.ac.kr J Korean Med Assoc
More informationLincoln College of Postprofessional, Graduate and Continuing Education. Case Presentation 1. Instructor: Lisa Shaver, ND, LAc
Lincoln College of Postprofessional, Graduate and Continuing Education Case Presentation 1 Instructor: Lisa Shaver, ND, LAc Faculty and Instructors representing NUHS/Lincoln College of Postprofessional,
More informationLincoln College of Postprofessional, Graduate and Continuing Education. Case Presentation 3. Instructor: Lisa Shaver, ND, LAc
Lincoln College of Postprofessional, Graduate and Continuing Education Case Presentation 3 Instructor: Lisa Shaver, ND, LAc Faculty and Instructors representing NUHS/Lincoln College of Postprofessional,
More informationNew Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome
New Tests and Treatments for Dyspepsia and Irritable Bowel Syndrome Soojong Hong Chae, MD Clinical Assistant Professor Digestive Diseases and Nutrition University of South Florida ROME III Functional dyspepsia
More information2018 SIBO Dispensary Guide
Dr Nirala Jacobi ND 2018 SIBO Dispensary Guide Version 1.1 08 June 2018 Copyright 2018 The SIBO Doctor Pty Ltd. All rights reserved. Dr Nirala Jacobi ND 2018 SIBO Dispensary Guide The natural treatment
More informationMANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES
Enrique Rey Professor of Medicine Head. Department of Digestive Diseases Hospital Clínico San Carlos Complutense University Madrid, Spain MANAGEMENT OF CHRONIC CONSTIPATION BEYOND LAXATIVES CONSTIPATION:
More informationNumber of studies. Endoscopic finding. Number of subjects. Pooled prevalence 95% CI
Clinical Approach to the Patient t with Dyspepsia William D. Chey, MD, FACG Professor of Medicine University of Michigan Prevalence of Endoscopic Findings in Individuals with Dyspepsia Systematic Review
More informationGastroparesis and other upper GI problems DR ANDREW DAVIES
Gastroparesis and other upper GI problems DR ANDREW DAVIES Outline Gastroparesis Hiccoughs Gastroparesis Gastroparesis Definition: A syndrome of objectively delayed gastric emptying in the absence of mechanical
More informationPrimary Management of Irritable Bowel Syndrome
Primary Management of Irritable Bowel Syndrome Jasmine Zia, MD Acting Instructor, Division of Gastroenterology Current Concepts in Drug Therapy CME Course April 23, 2015 Irritable Bowel Syndrome (IBS)
More informationSIBO: Clinical Strategies Online Certification Course
Source: boundless.com SIBO: Clinical Strategies Online Certification Course Allison Siebecker ND, MSOM, LAc www.siboinfo.com Invivo Clinical May, 2017 Dr. Siebecker 2012-2017 1 Class 2 Diagnosis: Testing
More informationCarminatives IBS C 11/12/10. Partial List of Carminatives and Secondary Benefits. Partial List of Carminatives and Secondary Benefits
IBS C Individuals experience a range of symptoms in addition to constipation (straining and hard stools) but also report abdominal pain and bloating as particularly troubling. Carminatives Estimated average
More informationDR ALLISON SIEBECKER
DR ALLISON SIEBECKER SIBO: Causes, Effects and Treatments Allison Siebecker ND, MSOM, LAc www.siboinfo.com Source: boundless.com SIBO Summit October 7 & 9 2016 Australia Dr. Siebecker 2016 SIBO Definition
More informationManagement of Functional Dyspepsia (FD)
Management of Functional Dyspepsia (FD) Amy S. Oxentenko, MD, FACG Program Director and Associate Chair, IM Associate Professor of Medicine Mayo Clinic, Rochester Outline Define functional dyspepsia (FD)
More informationSmall Intestinal Bacterial Overgrowth: Updates and Clinical Implications. Christine Stubbe, ND, FABNO
Small Intestinal Bacterial Overgrowth: Updates and Clinical Implications Christine Stubbe, ND, FABNO Lahnor Powell, ND, MPH Medical Education Specialist - Atlanta Christine Stubbe, ND, FABNO Technical
More informationNausea and Vomiting in Palliative Care
Nausea and Vomiting in Palliative Care Definitions Nausea - an unpleasant feeling of the need to vomit Vomiting - the expulsion of gastric contents through the mouth, caused by forceful and sustained contraction
More informationDYSPEPSIA Dyspepsia indigestion during or after eating Full Heat, burning or pain Note: one of every four people
What Is Dyspepsia? Dyspepsia, also known as indigestion, can have multiple symptoms. Feelings of indigestion happen during or after eating. If you have indigestion you might feel: Full during a meal. Painful
More informationConstipation An Overview. Definition Physiology of GI tract Etiology Assessment Treatment
CONSTIPATION Constipation An Overview Definition Physiology of GI tract Etiology Assessment Treatment Definition Constipation = the infrequent passage of hard feces Definition of Infrequent The meaning
More information14 days for RA (vs steroids)
14-21 days for SIBO On chart review, subjects who successfully normalized their breath test had a 66.4 +/- 36.1% improvement in bowel symptoms, compared to 11.9 +/- 22.0% in those who failed to normalize
More informationOur evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders.
Our evidence. Your expertise. SmartPill : The data you need to evaluate motility disorders. SmartPill benefits your practice: Convenient performed right in your office Test standardization Provides direct
More informationThe influence of early postoperative enteral feeding and promotility drugs on upper GI tract and gallbladder motility in the critical care setting
The influence of early postoperative enteral feeding and promotility drugs on upper GI tract and gallbladder motility in the critical care setting Alan Šustić, MD, PhD Dept. of Anesthesiology and ICU Univ.
More informationThe PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia. Disclosures
The PPI Doesn t Work, Now What? PPI Non-responsive Dyspepsia Lana Bistritz MD FRCPC Royal Alexandra Hospital GI Update 2016 Disclosures I have no relevant financial disclosures I will be discussing off
More informationApproach to Nausea & Vomi2ng
Approach to Nausea & Vomi2ng Med 3 Seminar 2017 Dr. Robin Grant Division of Pallia2ve Medicine robin.grant@nshealth.ca Why nausea and vomi2ng? Pain 80-90+ % Fa2gue / asthenia 75-90% Cons2pa2on 70% Dyspnea
More informationRestless Leg Syndrome The Role of SIBO and Inflammation
Lincoln College of Postprofessional, Graduate and Continuing Education Restless Leg Syndrome The Role of SIBO and Inflammation Instructor: Leonard Weinstock, MD, FACG Faculty and Instructors representing
More informationGastroparesis or Cyclic Vomiting: Does it Matter for Treatment?
Gastroparesis or Cyclic Vomiting: Does it Matter for Treatment? Brian E. Lacy, MD, PhD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology & Hepatology
More informationPathophysiology/Etiology As with most diseases in the veterinary
VETTALK Volume 15, Number 04 American College of Veterinary Pharmacists THE HARD TRUTH ABOUT PROKINETIC MEDICATION USE IN PETS Introduction The moving topic of this Vet Talk newsletter will be prokinetic
More informationIBS. Patient INFO. A Guide to Irritable Bowel Syndrome
Patient INFO IBS A Guide to Irritable Bowel Syndrome The information provided by the AGA Institute is not medical advice and should not be considered a replacement for seeing a medical professional. About
More informationGASTROPARESIS. C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis
GASTROPARESIS C. Prakash Gyawali, MD Professor of Medicine Washington University in St. Louis Symptom Definitions Nausea: a subjective feeling of wanting to vomit Vomiting: forceful expulsion of gastroduodenal
More informationIs one of the most common chronic disorders. causing patients to seek medical treatment.
ILOs After this lecture you should be able to : Define IBS Identify causes and risk factors of IBS Determine the appropriate therapeutic options for IBS Is one of the most common chronic disorders causing
More informationUse of Prokinetic Agents in Intensive Care Medicine - What is Evidence Based? Dr Martin Sterba PhD EDIC CICM TWH ICU, NSW, Australia
Use of Prokinetic Agents in Intensive Care Medicine - What is Evidence Based? Dr Martin Sterba PhD EDIC CICM TWH ICU, NSW, Australia Ostrava Ostrava Wollongong Wollongong Wollongong Prokinetics and EBM
More informationIBS Irritable Bowel syndrome Therapeutics II PHCL 430
Salman Bin AbdulAziz University College Of Pharmacy IBS Irritable Bowel syndrome Therapeutics II PHCL 430 Email:- ahmedadel.pharmd@gmail.com Ahmed A AlAmer PharmD R.S is 32-year-old woman experiences intermittent
More informationOutline. Definition (s) Epidemiology Pathophysiology Management With an emphasis on recent developments
Chronic Dyspepsia Eamonn M M Quigley MD FRCP FACP MACG FRCPI Lynda K and David M Underwood Center for Digestive Disorders Houston Methodist Hospital Houston, Texas Outline Definition (s) Epidemiology Pathophysiology
More informationPropulsion and mixing of food in the alimentary tract Chapter 63
Propulsion and mixing of food in the alimentary tract Chapter 63 Types of GI movements: Propulsive movement-peristalsis Propulsion: controlled movement of ingested foods, liquids, GI secretions, and sloughed
More informationIBS - Definition. Chronic functional disorder of GI generally characterized by:
IBS - Definition Chronic functional disorder of GI generally characterized by: 3500 3000 No. of Publications 2500 2000 1500 1000 Irritable Bowel syndrome Irritable Bowel Syndrome 500 0 1968-1977 1978-1987
More informationFunctional Dyspepsia
Functional Dyspepsia American College of Gastroenterology Boston Massachusetts, June 2015 Brian E. Lacy, PhD, MD, FACG Professor of Medicine Geisel School of Medicine at Dartmouth Chief, Section of Gastroenterology
More informationGastroparesis. - Recent advances in the pathophysiology and treatment -
ICDM 2015 Gastroparesis - Recent advances in the pathophysiology and treatment - Department of Internal Medicine, College of Medicine, St. Paul s hospital, The Catholic University of Korea, Seoul, Korea
More informationDr. Patsy Smyth, FNP-BC
Dr. Patsy Smyth, FNP-BC Gastroparesis literally translated means stomach paralysis. Gastroparesis is a syndrome characterized by delayed gastric emptying in absence of mechanical obstruction of the stomach.
More informationSTRATEGIES TO IMPROVE ENTERAL FEEDING TOLERANCE. IS IT WORTH IT? ENGELA FRANCIS RD(SA)
STRATEGIES TO IMPROVE ENTERAL FEEDING TOLERANCE. IS IT WORTH IT? ENGELA FRANCIS RD(SA) DEFINITION OF ENTERAL FEEDING INTOLERANCE Gastrointestinal feeding intolerance are usually defined as: High gastric
More informationHompes Method. Practitioner Training Level II. Lesson Eight Part 1C SIBO Protocols
Hompes Method Practitioner Training Level II Lesson Eight Part 1C SIBO Protocols Health for the People Ltd not for reuse without expressed permission Hompes Method is a trading name of Health For The People
More informationDigestion: Soothing Irritable Bowel
Digestion: Soothing Irritable Bowel Dr. Ritamarie Loscalzo Medical Disclaimer: The information in this presentation is not intended to replace a one on one relationship with a qualified health care professional
More informationDrugs Affecting the Gastrointestinal System. Antacids, Constipation, Increasing gastrointestinal motility
Drugs Affecting the Gastrointestinal System Antacids, Constipation, Increasing gastrointestinal motility Cells of the Gastric Gland parietal cells: produce & secrete HCl primary site of action for many
More informationRefractory GERD : case presentation and discussion
Refractory GERD : case presentation and discussion Ping-Huei Tseng National Taiwan University Hospital May 19, 2018 How effective is PPI based on EGD? With GERD symptom 75% erosive 25% NERD Endoscopy 81%
More informationCopy right protected Page 1
DRUGS USED IN ULCERS AND GIT DISORDERS A peptic ulcer, also known as PUD or peptic ulcer disease is an ulcer of an area of the gastrointestinal tract that is usually acidic and thus extremely painful.
More informationDefinition, Pathogenesis, and Management of That Cursed Dyspepsia
Clinical Gastroenterology and Hepatology 2018;16:467 479 Definition, Pathogenesis, and Management of That Cursed Dyspepsia Pramoda Koduru, Malcolm Irani, and Eamonn M. M. Quigley IM F1 김영기 Dyspepsia Umbrella
More informationWhat is Irritable Bowel Syndrome (IBS)?
What is Irritable Bowel Syndrome (IBS)? Irritable bowel syndrome (IBS) is a health issue found in your intestines (gut). IBS can cause symptoms such as: Belly pain. Cramping. Gas. Bloating (or swelling)
More informationPRUCAPLA Tablets (Prucalopride)
Published on: 2 May 2018 PRUCAPLA Tablets (Prucalopride) Composition PRUCAPLA 1 mg Each film coated tablet contains: Prucalopride succinate equivalent to Prucalopride 1 mg Excipients. q. s. Color: Titanium
More informationAre adhesions the missing link" in unresolved SIBO? Financial Disclosures
Are adhesions the missing link" in unresolved SIBO? Larry Wurn, LMT, Research Chair Clear Passage Physical Therapy Belinda Wurn, PT, Clinical Director Financial Disclosures Owner, Clear Passage Physical
More informationGastrointestinal Physiology. Intensive Care Training Program Radboud University Nijmegen Medical Centre
Gastrointestinal Physiology Intensive Care Training Program Radboud University Nijmegen Medical Centre Content Gastrointestinal blood flow Portal hypertension Motility disorders Specific metabolic disorders
More informationPharmacy Benefit Determination Policy
Policy Subject: Opioid Induced Constipation Policy Number: SHS PBD11 Category: GI Agents Policy Type: Medical Pharmacy Department: Pharmacy Product (check all that apply): Group HMO/POS Individual HMO/POS
More informationPosttest Questions and Rationale PDF document for posting.
Understanding Medical Foods in the Pharmacy Posttest Questions and Rationale PDF document for posting. 1. A physician asks a pharmacist to supply CerefolinNAC for a patient who has mild cognitive impairment
More informationMANAGEMENT OF VISCERAL PAIN
MANAGEMENT OF VISCERAL PAIN William D. Chey, MD, FACG Professor of Medicine University of Michigan 52 year old female with abdominal pain 5 year history of persistent right sided burning/sharp abdominal
More informationGI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics. Dr. Alia Shatanawi
GI Pharmacology -4 Irritable Bowel Syndrome and Antiemetics Dr. Alia Shatanawi 11-04-2018 Drugs used in Irritable Bowel Syndrome Idiopathic, chronic, relapsing disorder characterized by abdominal discomfort
More informationSIBO
SIBO What is it? Small Intestinal Bowel Overgrowth A chronic bacterial infection of the small intestine Caused by bad bacteria such as E Coli and Clostridium migrating to the small intestine There is not
More informationDisclosures. GI Motility Disorders. Gastrointestinal Motility Disorders & Irritable Bowel Syndrome
Gastrointestinal Motility Disorders & Irritable Bowel Syndrome None Disclosures Jasmine Zia, MD Acting Assistant Professor Division of Gastroenterology, University of Washington 6 th Asian Health Symposium
More informationA Guide to Help You Reduce and Stop Using Tobacco
Let s Talk Tobacco A Guide to Help You Reduce and Stop Using Tobacco Congratulations for taking this first step towards a healthier you! 1-866-710-QUIT (7848) albertaquits.ca It can be hard to stop using
More informationCHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University
CHAPTER 11 Functional Gastrointestinal Disorders (FGID) Mr. Ashok Kumar Dept of Pharmacy Practice SRM College of Pharmacy SRM University 1 Definition of FGID Chronic and recurrent symptoms of the gastrointestinal
More informationDigestion. Absorption and Transport. Digestion. Digestion. (Chapter 3) Your GI tract is like a tube!
Digestion Absorption and Transport Digestion the process of breaking down food into its basic components so they can be absorbed CHO, fat, pro are hydrolysed Vits, mins, water aren t (Chapter 3) Digestion
More informationPharmacology. -Alia Shatnawi
Pharmacology -3 -Alia Shatnawi Gastroesophageal reflux disease (GERD): a digestive disorder that affects the lower esophageal sphincter, characterized by reflux of acids from the stomach to the esophagus
More informationOverview of digestion
Key concepts in Digestion. Overview of digestion introduction to the GI system Prof. Barry Campbell Cellular & Molecular Physiology e-mail: bjcampbl@liv.ac.uk http://pcwww.liv.ac.uk/~bjcampbl DIGESTION
More informationEnhanced Recovery after Surgery - A Colorectal Perspective. R Sim Centre for Advanced Laparoscopic Surgery, TTSH
Enhanced Recovery after Surgery - A Colorectal Perspective R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus resolves Opioid
More informationAt the outset, we want to clear up some terminology issues. IBS is COPYRIGHTED MATERIAL. What Is IBS?
1 What Is IBS? At the outset, we want to clear up some terminology issues. IBS is the abbreviation that doctors use for irritable bowel syndrome, often when they are talking about people with IBS. We will
More informationHompes Method. Practitioner Training Level II. Lesson Eight The 4Rs Part B (ii) Restore
Hompes Method Practitioner Training Level II Lesson Eight The 4Rs Part B (ii) Restore Health for the People Ltd not for reuse without expressed permission Hompes Method is a trading name of Health For
More informationDisclosures. Objectives. Gastroparesis: Are We Moving On? Gastroparesis: Clinical Overview
Gastroparesis: Are We Moving On? Anthony Lembo, M.D. Associate Professor of Medicine Harvard Medical School Beth Israel Deaconess Medical Center Boston, MA Disclosures Consultant Alkermes, Allergan, Forest,
More informationToday- 90 minutes! Sustainable commitment - what is that and and why is it a challenge? Early symptoms and vulnerability.
Today- 90 minutes! Sustainable commitment - what is that and and why is it a challenge? Early symptoms and vulnerability Restoration Remaining healthy - Strategies Student commitment challenges - Stress-vulnerability
More informationEmerging Treatments for IBS-C and Clinical Trial Endpoints
Emerging Treatments for IBS-C and Clinical Trial Endpoints Lin Chang, M.D. Oppenheimer Family Center for Neurobiology of Stress David Geffen School of Medicine at UCLA Learning Objectives Describe current
More informationInternational Congress of the Italian Association of Companion Animal Veterinarians
www.ivis.org International Congress of the Italian Association of Companion Animal Veterinarians 2 - May, 201 Rimini, Italy Next Congress : SCIVAC International Congress Ma -, 201 -, Italy Reprinted in
More informationDr. Melissa Kagarise, PA C
Dr. Melissa Kagarise, PA C This program has been supported by an educational grant from Pfizer Pharmaceuticals PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of
More informationDigestive Health Symptomatic Relief Suggestions
Digestive Health Symptomatic Relief Suggestions Here are a list of suggestions in case you end up with constipation, bloating and stomach pain, diarrhea and/or indigestion/acid reflux. These are some great
More informationObjectives. Pain Types Brief Review. Referred Pain. Chronic/Recurrent Abdominal Pain 1/12/2017. I have no conflicts of interest to disclose
Joshua D Noe, MD Associate Professor of Pediatric Gastroenterology Hepatology and Nutrition Medical College of Wisconsin I have no conflicts of interest to disclose Objectives Differentiate functional
More informationStraight Talk on. Women s GI Health. By Judith Reichman, MD, women s health specialist. A new nationwide health campaign for women over age 40
Straight Talk on Women s GI Health By Judith Reichman, MD, women s health specialist A new nationwide health campaign for women over age 40 welcome! As a gynecologist for more than 25 years, I have seen
More informationOpioid-Induced Constipation
Objectives Opioid-Induced Constipation Brianna Jansma, PharmD Alex Smith, PharmD Megan Robinson, PharmD Summarize epidemiology of opioid-induced constipation (OIC) Understand opiates effects on the gastrointestinal
More informationGastroparesis: Diagnosis and Management
Gastroparesis: Diagnosis and Management Rodica Pop-Busui MD, PhD Professor of Internal Medicine, Metabolism, Endocrinology and Diabetes, University of Michigan, Ann Arbor, MI Disclosures Astra Zeneca Research
More informationEDUCATION PRACTICE. Management of Delayed Gastric Emptying. Clinical Scenario. The Problem. Management Strategies and Supporting Evidence
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:642 646 EDUCATION PRACTICE Management of Delayed Gastric Emptying FRANK K. FRIEDENBERG and HENRY P. PARKMAN Temple University Hospital, Philadelphia, Pennsylvania
More informationAmyloidosis & the GI Tract
Amyloidosis & the GI Tract John O. Clarke, M.D. Director, Esophageal Program Clinical Associate Professor of Medicine Stanford University john.clarke@stanford.edu 2017 Topics to cover 1) Patterns of GI
More informationCurrent and Emerging Pharmacological Treatments in Irritable Bowel Syndrome
Current and Emerging Pharmacological Treatments in Irritable Bowel Syndrome Anthony Lembo, M.D. Associate Professor of Medicine Beth Israel Deaconess Medical Center Harvard Medical School What is the general
More informationFast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery. R Sim Centre for Advanced Laparoscopic Surgery, TTSH
Fast Track Surgery and Surgical Carepath in Optimising Colorectal Surgery R Sim Centre for Advanced Laparoscopic Surgery, TTSH Conventional Surgery Postop care Nasogastric tube Enteral feeds when ileus
More informationReflux of gastric contents, particularly acid, into the esophagus
Heartburn Reflux of gastric contents, particularly acid, into the esophagus Patient assessment with GERD 1-signs and symptoms The hallmark of typical symptom of GERD is heartburn (restrosternal),acid regurgitation,
More informationWhat part of the gastrointestinal (GI) tract is composed of striated muscle and smooth muscle?
CASE 29 A 34-year-old man presents to his primary care physician with the complaint of increased difficulty swallowing both solid and liquid foods. He notices that he sometimes has more difficulty when
More informationPharmacotherapy for IBS
Pharmacotherapy for IBS Brooks D. Cash, M.D., FACG Chief, Gastroenterology Professor of Medicine University of South Alabama Director, GI Physiology, USA Medical Center Mobile, AL Disclosures I have served
More informationsolvingleakygut.com Welcome to the 5 Day Constipation Plan
solvingleakygut.com Welcome to the 5 Day Constipation Plan The Goals of this 5 Day Constipation Protocol: 1. Significantly improve your stool frequency and quality (The final goal is 1-3 bowel movements
More informationHeartburn. Understanding and Treating. Heal n Cure For appointments call
A C P S P E C I A L R E P O R T Understanding and Treating Heartburn What is Heartburn? It begins as a burning pain in the middle of your chest, behind the breastbone, often after a big meal. The burning
More informationSymptom Management. Thomas McKain, MD, ABFM, ABHPM Medical Director
Symptom Management Nausea & Vomiting Thomas McKain, MD, ABFM, ABHPM Medical Director Mr. Jones has nausea and vomiting. May I initiate Compazine from the Comfort Pak? Objectives 1. Delineate the Differential
More informationPediatric Intake Paperwork. Personal History
Pediatric Intake Paperwork Child s Name: Date: Address: City: Zip: Cell Phone: Work Phone: Email: Date of Birth: Social Security Number: Your occupation: Your employer: Whom to contact in case of emergency?
More informationMedication Safety Presentation
Appendix E Aid 1: Sample Event Poster Medication Safety Presentation Do YOU know your role on the healthcare team? Do YOU know the questions to ask your pharmacist? Do YOU know safe medication practices?
More informationInnovative Management of Pain Through Compounding. Shawn Needham R.Ph.
Innovative Management of Pain Through Compounding Shawn Needham R.Ph. Disclosure Shawn Needham is a compounding pharmacist and does have interest in a compounding pharmacy Compounded pharmaceuticals are
More informationDavid Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:
David Leff, DO AOMA 94 th Annual Convention April 13, 2016 Disclosure I have the following financial relationships to disclosure: Speaker s Bureau: Allergan Labs, Takeda Pharmaceutical, Valeant Pharmaceutical
More informationPatient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet
Page 1 of 6 Patient information sheet: BuTrans Patch This information should be read in conjunction with the Taking Opioids for pain information leaflet What type of drug is it? BuTrans transdermal patches
More informationHelicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.
An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology
More informationDisclosures. IPF Medications: Practical Experience. Prednisone, Azathioprine, N acyetylcysteine. Case 1. Brett Ley, MD, MAS Assistant Professor, UCSF
IPF Medications: Practical Experience Disclosures Received speakers bureau honorarium from Roche/Genentech (makers of pirfenidone). Brett Ley, MD, MAS Assistant Professor, UCSF 67 y/o man 1 year cough
More informationRecent advances in pharmacological treatment of irritable bowel syndrome
Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.3748/wjg.v20.i27.8867 World J Gastroenterol 2014 July 21; 20(27): 8867-8885 ISSN 1007-9327 (print)
More informationDOMPERIDONE BNF 4.6. Domperidone is a dopamine type 2-receptor antagonist. It is structurally related to the
DOMPERIDONE BNF 4.6 Class: Prokinetic anti-emetic. Indications: Nausea and vomiting, dysmotility dyspepsia, gastro-oesophageal reflux. Pharmacology Domperidone is a dopamine type 2-receptor antagonist.
More informationPeptic Ulcer Disease Update
Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following
More informationManagement of Gastroparesis
Management of Gastroparesis Bible Class Jan Hendrik Niess As published in Am J Gastroenterol. 2013 Jan;108(1):18-37 What is the definition of gastroparesis? What are cardinal symptoms of gastroparesis?
More informationVomiting Approach to diagnosis
Vomiting Approach to diagnosis By Dr. Sahar El-Gharabawy Associate professor of internal medicine Hepato-gastroenterology Unit )SMH ) Mansoura University Definitions: Nausea: Feeling "sick to the stomach",
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More informationDESCRIPTION Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related to acetylcholine.
BETHANECHOL CHLORIDE TABLETS, USP 5 mg, 10 mg, 25 mg and 50 mg Rx only DESCRIPTION Bethanechol chloride, USP, a cholinergic agent, is a synthetic ester which is structurally and pharmacologically related
More informationDiabetic Gastroparesis. Evan M. Klass, MD, FACP February 16, 2017
Diabetic Gastroparesis Evan M. Klass, MD, FACP February 16, 2017 Scope of the problem The disorder can affect any part of the GI tract Although 10-20% of the general population suffer from functional GI
More informationTHE ROLE OF INTEGRATIVE HEALTH IN IBD CARE
THE ROLE OF INTEGRATIVE HEALTH IN IBD CARE Maria R. Mascarenhas February 2018 1 OBJECTIVES What is Integrative Health? How often is it used in patients in the US and in patients with IBD? What are the
More informationPATIENT CASE HISTORY. General Health Medications Allergies
OCULAR PHARMACOLOGY What I Need to Know Before I Medicate A Patient Lynn Lawrence, CPOT, ABOC, COA ROLE of the ASSISTANT AND TECHNICIAN Accurate documentation/recording Patient Education can assist in
More informationNausea & Vomiting. Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA
Nausea & Vomiting Dr Eve Lyn TAN Liverpool Hospital NSW, AUSTRALIA Prevalence prevalence varies *, systemic review 2007 : overall prevalence : nausea 30%, vomiting 20% in last 1-2 weeks of life : nausea
More information